Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Apple | AAPL | Oct 17, 2024 | 232.15 | +0.16 |
Apple Hospitality REIT | APLE | Oct 17, 2024 | 15.23 | -0.07 |
Applied Digital | APLD | Oct 17, 2024 | 7.95 | -1.24 |
Applied DNA Sciences | APDN | Oct 17, 2024 | 0.32 | +0.96 |
Applied Industrial Technologies | AIT | Oct 17, 2024 | 235.15 | +0.32 |
Applied Materials | AMAT | Oct 17, 2024 | 183.24 | -0.73 |
Applied Optoelectronics | AAOI | Oct 17, 2024 | 19.00 | +0.16 |
Applied Therapeutics | APLT | Oct 17, 2024 | 8.63 | -1.88 |
Applovin A | APP | Oct 17, 2024 | 143.00 | -1.28 |
AppTech Payments | APCX | Oct 17, 2024 | 0.73 | +1.26 |
Aprea Therapeutics | APRE | Oct 17, 2024 | 4.45 | +27.14 |
AptarGroup | ATR | Oct 17, 2024 | 167.89 | +1.11 |
Aptevo Therapeutics | APVO | Oct 17, 2024 | 0.16 | +3.48 |
Aptiv | APTV | Oct 17, 2024 | 69.90 | -0.65 |
Aptorum Group A | APM | Oct 17, 2024 | 1.66 | -1.78 |
Aptose Biosciences | APTO | Oct 17, 2024 | 0.36 | -2.17 |
APx Acquisition I A | APXI | Oct 17, 2024 | 11.72 | 0.00 |
APx Acquisition I Unit | APXIU | Oct 17, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Oct 17, 2024 | 1.19 | -3.25 |
Aqua Metals | AQMS | Oct 17, 2024 | 0.15 | -5.51 |
AquaBounty Technologies | AQB | Oct 17, 2024 | 1.16 | -3.33 |
Aquaron Acquisition | AQU | Oct 17, 2024 | 11.00 | 0.00 |
Aquaron Acquisition Units | AQUNU | Oct 17, 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | Oct 17, 2024 | 4.92 | -0.20 |
Aramark | ARMK | Oct 17, 2024 | 39.02 | -0.96 |
ARB IOT Group | ARBB | Oct 17, 2024 | 0.31 | +1.26 |
Arbe Robotics | ARBE | Oct 17, 2024 | 2.05 | +2.76 |
Arbor Realty Trust | ABR | Oct 17, 2024 | 15.19 | -0.65 |
Arbor Realty Trust D Pref | ABR-D | Oct 17, 2024 | 19.54 | +0.09 |
Arbor Realty Trust E Pref | ABR-E | Oct 17, 2024 | 20.23 | +2.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.